Rhythm Biosciences Limited (ASX:RHY)
Australia
· Delayed Price · Currency is AUD 0.220
+0.020 (10.00%)
Mar 10, 2026, 10:28 AM AEST
Rhythm Biosciences Income Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | 2020 - 2017 |
| Other Revenue | 3.19 | 3.19 | 1.69 | 3.1 | 2.43 | 1.11 | Upgrade
|
| Revenue | 1.65 | 3.19 | 1.69 | 3.1 | 2.43 | 1.11 | Upgrade
|
| Revenue Growth (YoY) | -47.96% | 88.85% | -45.41% | 27.54% | 118.98% | 1008.51% | Upgrade
|
| Cost of Revenue | 0.63 | 0.22 | 3.05 | - | - | - | Upgrade
|
| Gross Profit | 1.01 | 2.97 | -1.36 | 3.1 | 2.43 | 1.11 | Upgrade
|
| Selling, General & Admin | 6.03 | 5.12 | 3 | 7.7 | 5.99 | 3.03 | Upgrade
|
| Research & Development | 1.38 | 1.38 | 2.35 | 3.65 | 5.16 | 4.55 | Upgrade
|
| Amortization of Goodwill & Intangibles | - | - | - | 0.04 | 0.04 | 0.04 | Upgrade
|
| Operating Expenses | 7.62 | 6.7 | 5.55 | 11.54 | 11.25 | 7.73 | Upgrade
|
| Operating Income | -6.6 | -3.73 | -6.91 | -8.44 | -8.82 | -6.62 | Upgrade
|
| Interest Expense | -0.08 | -0.07 | -0 | -0.01 | - | -0 | Upgrade
|
| Interest & Investment Income | 0.07 | 0.13 | 0.05 | 0.23 | 0.02 | 0.01 | Upgrade
|
| EBT Excluding Unusual Items | -6.61 | -3.66 | -6.86 | -8.22 | -8.79 | -6.61 | Upgrade
|
| Merger & Restructuring Charges | -0.07 | -0.17 | - | - | - | - | Upgrade
|
| Pretax Income | -6.68 | -3.83 | -6.86 | -8.22 | -8.79 | -6.61 | Upgrade
|
| Net Income | -6.68 | -3.83 | -6.86 | -8.22 | -8.79 | -6.61 | Upgrade
|
| Net Income to Common | -6.68 | -3.83 | -6.86 | -8.22 | -8.79 | -6.61 | Upgrade
|
| Shares Outstanding (Basic) | 300 | 269 | 228 | 217 | 210 | 185 | Upgrade
|
| Shares Outstanding (Diluted) | 300 | 269 | 228 | 217 | 210 | 185 | Upgrade
|
| Shares Change (YoY) | 22.10% | 17.94% | 5.26% | 3.31% | 13.35% | 83.84% | Upgrade
|
| EPS (Basic) | -0.02 | -0.01 | -0.03 | -0.04 | -0.04 | -0.04 | Upgrade
|
| EPS (Diluted) | -0.02 | -0.01 | -0.03 | -0.04 | -0.04 | -0.04 | Upgrade
|
| Free Cash Flow | -6.14 | -2.94 | -6.22 | -7.06 | -6.52 | -5.47 | Upgrade
|
| Free Cash Flow Per Share | -0.02 | -0.01 | -0.03 | -0.03 | -0.03 | -0.03 | Upgrade
|
| Gross Margin | 61.47% | 92.95% | -80.31% | 100.00% | 100.00% | 100.00% | Upgrade
|
| Operating Margin | -400.74% | -116.85% | -408.60% | -272.60% | -363.29% | -597.64% | Upgrade
|
| Profit Margin | -405.14% | -119.97% | -405.69% | -265.44% | -362.26% | -596.49% | Upgrade
|
| Free Cash Flow Margin | -372.52% | -92.25% | -367.98% | -227.94% | -268.74% | -493.52% | Upgrade
|
| EBITDA | -6.4 | -3.53 | -6.71 | -8.34 | -8.72 | -6.52 | Upgrade
|
| EBITDA Margin | - | -110.68% | - | -269.35% | - | - | Upgrade
|
| D&A For EBITDA | 0.2 | 0.2 | 0.2 | 0.1 | 0.09 | 0.11 | Upgrade
|
| EBIT | -6.6 | -3.73 | -6.91 | -8.44 | -8.82 | -6.62 | Upgrade
|
| EBIT Margin | - | -116.85% | - | -272.60% | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.